October 9, 2017 6:21pm
I answer one question, in which company should investors commit and keep their money.
Pre-open indications: 7 hit and 0 miss
Out and about: MiMedx Group (MDXG), authorized a $10 million increase in the Share Repurchase Program bringing the total authorized to $110 million since the it commenced in May 2014.
Q3 results kick-off: Athersys, Inc. (ATHX) will release its Q3/17 financial results at approximately 4:00 PM ET on Wednesday, 11/8/17, and will host a conference call shortly thereafter at 4:30 PM ET to review the results.
In the grip of rotating cycles and disparaging trends, what is the price of sector knowledge – a subscription!
Why is it that traders are mostly looking for the exit door, because companies never opened the front door and welcome them for a reality status to wallet conversation?
Quarterly calls and conversations need to be more than every fourth month ...
What ever happened to “Dear Investor” update letters?
Monday’s results have implications to Tuesday’s sector activity as a daily report may say little or a lot and it serves as insurance that all indications are being examined and evaluated!
Henry’omics:
From the pre-open’s newsletter “what are the dynamics in cell therapy investing … short-termism and skepticism. Until positive data with guidance is infused with sustainability, the contagions will linger.”
When was the last time, you as an investor HEARD from the CEO of “your” dollar investment?
- Probably haven’t other than quarterly and then talk at the wall in their own conference room – says why many investors have exited and traders usually see an exit!
Reiterating, “The pessimism comes as fundaments are skewed while momentum ebbs and flows. Those aspects define the short-termism and skepticism as a dynamic, explaining unexpected rises followed by a stampede of traders emptying their positions as algorithms and ETF exposure ensure their divesture.”
- That said, any recent stock gains will be subject to scrutiny and will be bitten by the snake of timing when investors find fewer reasons to stay long!
The advance/decline line scenario of 43 SCGT & RT covered companies:
· The open was negative with an A/DL of 14/23 and 6 flats;
· 10:30 am was negative with an A/DL of 14/26 and 3 flats;
· The mid-day was negative with an ADL of 14/28 and 1 flats;
· The close was negative with an A/DL of 13/26 and 4 flats;
Pre-open indications: 7 hit and 0 miss
· Athersys (ATHX) closed down -$0.00 – hit;
· BioLife Solutions (BLFS) closed down -$0.02 - hit;
· Cytori Therapeutics (CYTX) closed down -$0.0949 – hit;
· Mesoblast (MESO) closed down -$0.06 – hit;
· Cesca Therapeutics (KOOL) closed down -$0.25 – hit;
· Sangamo Therapeutics (SGMO) closed up +$0.10 – hit;
· Vericel (VCEL) closed down -$0.30 – hit;
Out and about:
MiMedx Group, Inc. (MDXG) authorized a $10 million increase in the company's Share Repurchase Program.
- This action by the MiMedx Board of Directors authorizing the additional $10 million to the “Share Repurchase Program” brings the total authorized to $110 million since the Share Repurchase Program commenced in May 2014. The Company reported that in light of the short seller attacks and its strong balance sheet and cash flows, the MiMedx Board of Directors believes the stock repurchases continue to be an extremely positive investment for MiMedx. The Board also agreed to review this program again at its scheduled meeting on October 26, 2017, and to consider an additional commitment at that time.
Some of MY working trend lines or indications:
… The greatest volume to the downside: CYTX, MDXG, CAPR, VCEL and ONVO
… Upside volume was weighted to: IMUC, BSTG, JUNO, RENE.L and BLUE
… Biggest $ downside: ONCE (-$1.77), RGNX (-$1.35), MDXG (-$0.41), VCEL (-$0.30) and XON (-$0.29)
… Largest $ upside: BLUE (+$3.75), RENE.L (+$0.20), ISCO (+$0.15), PSTI (+$0.07) and FCSC (+$0.07)
… Flat: KITE at $179.79, ATHX at $2.42, ADVM at $3.55, AXGN at $18.65 and NWBO at $0.17
Counting the week’s apples:
CAPR closed down -$0.19 - CAPR can’t keep fooling investors for long with their brand of hype…I still think the HYPE is overplayed …
VCEL was down again -$0.40 – an Icarus flight and should have financed in an overnight … short sighted management
As HSGX closed down -$0.07 after a week of ups (+$0.21) … traders became nervous …
While AXGN was flat again while MDXG was down -$0.41 … the merry-go-round turns;
AGTC was up +$0.05 after being flat at $4.00 on Friday. I haven’t seen or heard of ANY officer buys … AGTC can’t escape the downside trap …
AST was down again -$0.05 while mothership BTX was up +$0.04 … they both NEED cash to prop their balance sheets
Cellectis S.A. (CLLS) dumped again another -$0.19 after Friday’s -$0.28 as I had stated … watch the merry-go-round but, don’t wait for the music to stop;
Immuno-oncologists - JUNO was up +$0.07 after Friday’s -$1.11; KITE was flat again at $179.79 while BLCM was down -$0.21 after Friday’s -$0.07 as VSTM slipped -$0.01 after Friday’s -$0.14;
ATHX was flat after Friday’s -$0.03 as many STILL question their cash position going forward and their clinical “manufacturing” issues as trials continue …
RGNX was down -$1.35 after Friday’s +$0.50 opting to back away from a deal to buy Dimension Therapeutics Inc. (DMTX). RGNX had announced plans to buy Dimension in an all-stock transaction. Any time one has a doubt – wait, RGNX usually rebounds … by walking they receive $2.85 M … I keep telling you!
SGMO got slashed again -$0.10 after Friday’s -$0.70 while ONCE was down again -$1.77 after Friday’s -$0.04 as BLUE jumped +$3.75 after Friday’s +$1.75 …
FATE was up +$0.06 after Friday’s -$0.08 – hang in;
MESO dumped again -$0.06 after Friday’s -$0.30 – time to be accumulating …
CYTX was down -$0.094 after Friday’s +$0.14 – still looking at “strategic options” while another criminal, OSIR was down again -$0.09 after Friday’s -$0.06 – until they can “clean-up” the past non-filings and criminal complaints, they are NOT VIABLE …
PSTI was up +$0.07 after Friday’s down -$0.01 after being flat at $1.50 after being up +$0.03 following being on the losing side of the trade -$0.06, when will they ever learn – it has to be considered trustworthy by shareholders
Daily analytics:
U.S. stocks closed lower on Monday in a thinly traded session. The U.S. bond market was closed in observance of Columbus Day, which contributed to the light trading action in equities.
· The Dow dipped 12.6 points, or less than 0.1%, to 22,761, though it hit an intraday record of 22,803.37 in early trading.
· The S&P 500 slipped 4.6 points, or 0.2%, to 2,545. The benchmark equity index traded less than a point from its own intraday peak at its high of the session.
· The NASDAQ lost 10.5 points to 6,580, a drop of about 0.2%, though the tech-heavy index touched an all-time high of 6,599.34 in early trading.
The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market; Monday traded at 10.33, up +7.05% …
- Friday traded 9.65, up +5.01% after Thursday traded at 9.19, down -4.57% after Wednesday traded at 9.63, up +1.26% after Tuesday traded at 9.57, up +1.27 after last Monday traded at 9.45, down -0.63% …
Welcome to another day of the sector’s roller coaster …
… The iShares Russell 2000 (IWM) indicated:
· Monday was down -0.41%
· Friday -0.11%
· Thursday +0.27%
· Wednesday -0.30%
· Tuesday +0.21%
· Last Monday +1.23
… The Russell 2000 (RUT)
· Monday lost -6.66 or -0.44%
· Friday lost -1.87 points or -0.12%
· Thursday gained 4.32 points, or 0.3%
… The iShares NASDAQ Biotechnology (IBB) indicated:
· Monday was down -0.29%
· Friday -0.11%
· Thursday +0.11%
· Wednesday +0.78%
· Tuesday -0.23%
· Last Monday +1.51%
The count - decliners versus gainers:
……. look at the differences in the spreads as decliners jump and %
· Monday’s decliners ranged from -0.22% <VSTM -$0.01> to -14.95% <CYTX -$0.0949> in 26 equities;
· Friday’s decliners ranged from -0.05% <ONCE -$0.04> to -52.40% <BSTG -$0.119> in 28 equities;
· Thursday’s decliners ranged from -0.05% <ONCE -$0.04> to -24.99% <BSTG -$0.08> in 21 equities;
· Wednesday’s decliners ranged from -0.42% <JUNO -$0.19> to -8.32% <KOOL -$0.40> in 16 equities;
· Tuesday’s decliners ranged from -0.45% <ONVO -$0.01> to -8.05% <MDXG -$1.03> in 23 equities;
· Last Monday’s decliners ranged from -0.01% <KITE -$0.02> to -8.66% <BLUE -$11.90> in 14 equities;
Versus
… Look at the percentage’s (%) and spreads …
· Monday’s gainers ranged from +0.16% <JUNO +$0.07> to +12.12% <RENE.L +$0.20> in 13 equities;
· Friday’s gainers ranged from +0.36% <BTX +$0.01> to +29.55% <CYTX +$0.14> in 12 equities;
· Thursday’s gainers ranged from +0.22% <OSIR -$0.01> to +24.49% <CYTX +$0.10> in 20 equities;
· Wednesday’s gainers ranged from +0.42% <VCEL +$0.025> to +6.38% <CYTX +$0.023> in 22 equities;
· Tuesday’s gainers ranged from +0.31% <XON +$0.06> to +33.98% <KOOL +$1.22> in 18 equities;
· Last Monday’s gainers ranged from +0.24% <ONCE +$0.21> to +13.86% <CAPR +$0.42> in 26 equities;
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
